Live in the Nesac Market site in the heart of New York City's Times Square.

This is Fast Money.

Here's what's on tap tonight.

Health care headaches, the S&P in Nesac at records but shares of Lillian Novo taking a hit.

The drug makers, the latest targets for President Biden,

their drug prices, they're going to become the next big hot button issue as we head into the election.

Plus Tesla revs up the EV maker's stock

charging toward its highs of the year,

but could it be about to hit the breaks?

One top analyst will weigh in.

And later, a seller's market, home building stocks

on shaky ground today.

After a big downgrade over at City, the Chartmaster will join us to lay out why you should

not be going into contract on these names.

I'm Melissa Lee, come to you live in the studio, be at the Nasak on the desk tonight.

Tim Seymour, Karen Finerman, Dan Nathan, and Bono and Eisen.

We start off with the op-ed that delta blow to shares of Novo Nordisk and Eli Lilly today.

President Biden, Vermont Senator Bernie Sanders

out with a new attack on the high sticker price

of GLP1 weight loss drug saying,

Novo and Lilly need to stop, quote,

ripping off the American people. the pair calling the price of treatment

...